High conversion rates to Parkinson's, dementia with Lewy bodies, or multiple system atroph ...

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces the appointment of ...

Brent crude briefly dumped below US$100 a barrel, while gold and silver surged as bond yields slid lower. Back on the ASX, ...

News and commentary from the world of neurology and neuroscience ...

Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ...

Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") .  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.

Kodiak Sciences Inc. , a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced it will present ...

Neuraly, Inc., a wholly owned subsidiary of D&D Pharmatech, Inc. (KOSDAQ: 347850), announced that the first patient has been ...

As AI and agents take on execution, our own agency expands. The question is whether organizations are built to capture it.

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...

Menopause is a profound neurological transition that reshapes cognitive architecture, emotional resilience, and sensory ...

The cognitive debt of digital leadershipWhy the pursuit of AI could quietly lead executives into advanced ignorance.Issued by CyberDexterityJohannesburg, 07 May 2026 Antonios (Tony) Christodoulou, CEO ...